It is better absorbed. That is the claim the evidence supports and the only one that can be made. Dihydroberberine is the reduced form of berberine, is more lipophilic, is a weaker substrate for intestinal efflux pumps, and is converted back into berberine once it has been absorbed. Whether that superior absorption translates into a better result for you is not something any UK seller is permitted to claim, and not something the published human literature on dihydroberberine — a single five-person pharmacokinetic pilot — is able to demonstrate.

No. There is no Great Britain restriction on berberine in food supplements at the time of writing. What has happened is that EFSA endorsed a draft scientific opinion in January 2026 concluding that a safe intake level for berberine could not be established from the available data, and opened a stakeholder consultation. The UK's Committee on Toxicity discussed that draft at its 31 March 2026 meeting. EFSA's final opinion is expected in 2027 and the European Commission would then decide on any EU action — which would apply in Northern Ireland but not automatically in Great Britain. Some EU member states have already acted independently: Sweden and Greece have reportedly prohibited berberine in supplements and Belgium has set a 10 mg per day level.

No. The mandate covers preparations of a defined list of berberine-containing plant species, and expressly excludes medicinal products and synthetic forms of berberine, which fall under the Novel Food Regulation instead. Dihydroberberine is a hydrogenated derivative rather than a plant preparation, so its regulatory route is the novel food regime rather than this opinion. Whether a specific dihydroberberine ingredient has a history of significant consumption in the UK or EU before 15 May 1997 — the test that regime applies — is a question for the ingredient supplier, and a reasonable one to ask any brand selling it.

On our Dihydroberberine 550mg, one serving is two capsules, taken once daily, and 550mg is the amount in that two-capsule serving rather than in each capsule. A 60-capsule pack is therefore 30 days. This distinction matters when comparing products: a competitor pack advertising a similar milligram figure per capsule is delivering roughly twice as much per serving, and one advertising it across four capsules is delivering half. Always read the nutrition panel rather than the front of the pack.

Follow the directions on the pack you buy, and start at the lowest amount those directions allow. For context rather than instruction: the only published human trial used 100mg and 200mg per dose. Our own product supplies 550mg per two-capsule daily serving, and most other UK products are labelled higher still — there is no published human data at those strengths. We are a manufacturer, not your clinician, so we do not give personalised dosing; that is advice we are not qualified to give. If you take any prescription medicine, ask your GP or pharmacist before starting.

Because health claims on food supplements in Great Britain must appear on the register of authorised claims, and berberine has none. It has no nutrient reference value either, which is why no percentage figure appears next to it on a label. Where you see a lawful blood-glucose statement on a UK pack containing berberine, that statement is being carried by a vitamin or mineral in the formula — chromium, most commonly — and not by the berberine. A brand asserting the claim for berberine itself is not operating within the rules.

Reduced gastrointestinal discomfort is the practical reason the reduced form was developed, and it follows logically from needing a smaller oral dose to achieve comparable blood levels — much of berberine's digestive effect comes from unabsorbed alkaloid remaining in the gut. Reported tolerance is generally better. But the human dataset is small, individual responses vary considerably, and taking any berberine form with food remains sensible.

Not necessarily. GlucoVantage is a trademarked branded dihydroberberine ingredient, and it is the material used in the 2021 human pharmacokinetic pilot. Generic dihydroberberine from other sources is the same molecule but is not covered by that study's specifications. If a branded ingredient matters to you, look for the trademark and its symbol in the ingredients list — if a pack does not name one, it is generic dihydroberberine.

Do not do this without speaking to your GP or pharmacist first. Berberine is independently associated with hypoglycaemia in regulatory assessments and interacts with drug-metabolising enzymes and transporters, so it can alter the blood levels of other medicines. Combining it with medication that already lowers blood glucose is precisely the scenario regulators have flagged. This is a conversation for a clinician who knows your prescriptions, not for a supplement website.

Both solve berberine's absorption problem by different routes. Dihydroberberine changes the molecule and relies on the body converting it back; a phytosome leaves berberine intact and changes what it travels with. Phytosome preparations have more human pharmacokinetic work behind them. Dihydroberberine achieves its effect from a smaller oral dose. If the novel-food question around synthetic derivatives concerns you, the phytosome does not raise it. There is no objectively correct answer, which is why we sell both.

No, and the phrase should be treated as a warning sign about the source using it rather than as information. It originated as a TikTok hashtag in 2023. Berberine and GLP-1 receptor agonists are entirely different classes of compound with entirely different mechanisms, dose ranges, evidence bases and regulatory status. No UK supplement may lawfully be marketed as an alternative to a prescription medicine. We cover the actual biology in berberine and GLP-1.